文献速递系统性红斑狼疮

系统性红斑狼疮母亲妊娠期暴露于羟氯喹或硫唑嘌呤所生儿童的结局

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

该回顾性研究分析了英国10个中心199名系统性红斑狼疮母亲的284例活产儿,比较妊娠期暴露于羟氯喹或硫唑嘌呤的儿童结局;羟氯喹暴露未显示显著不良结局,硫唑嘌呤暴露与儿童期需住院管理的感染报告增加相关(OR 2.283),作者认为需进一步研究。

要点

  • 羟氯喹暴露儿童未见显著不良结局。
  • 硫唑嘌呤暴露与儿童期需住院管理感染报告增加相关(OR 2.283)。
  • 硫唑嘌呤与低出生体重的关联仅在单变量模型中出现,多变量模型无显著关联。

核心结论

  • 妊娠期暴露于羟氯喹的儿童未显示显著不良结局。
  • 硫唑嘌呤暴露与儿童期需住院管理的感染报告增加相关,作者认为需进一步研究。

研究设计与样本

  • 回顾性研究,纳入英国10个专科狼疮门诊的199名系统性红斑狼疮母亲及其284例活产儿,儿童年龄≤17岁且出生于系统性红斑狼疮诊断之后。
  • 数据通过问卷和临床记录回顾收集,采用多变量混合效应logistic回归模型分析低出生体重和儿童期感染的相关因素。

主要发现

  • 284例活产儿中,150/248(60.4%)暴露于羟氯喹,87/280(31.1%)暴露于硫唑嘌呤。
  • 暴露与未暴露于羟氯喹或硫唑嘌呤的儿童之间,先天性畸形或宫内生长受限的频率无显著差异。
  • 有高血压或肾脏疾病史的女性中硫唑嘌呤使用增加。
  • 硫唑嘌呤在单变量模型中与低出生体重相关,但在多变量模型中无显著关联。

关键数值与推荐

  • 羟氯喹暴露与先天性畸形或宫内生长受限的频率无显著差异。
  • 硫唑嘌呤暴露与先天性畸形或宫内生长受限的频率无显著差异。
  • 硫唑嘌呤与低出生体重在多变量模型中无显著关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出硫唑嘌呤与儿童期感染报告增加的关联需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: HCQ and AZA are used to control disease activity and reduce risk of flare during pregnancy in patients with SLE. The aim of this study was to determine the outcomes of children born to mothers with SLE exposed to HCQ or AZA during pregnancy and breast-feeding. METHODS: Women attending UK specialist lupus clinics with children ≤17 years old, born after SLE diagnosis, were recruited to this retrospective study. Data were collected using questionnaires and from clinical record review. Factors associated with the outcomes of low birth weight and childhood infection were determined using multivariable mixed-effects logistic regression models. RESULTS: We analysed 284 live births of 199 mothers from 10 UK centres. The first pregnancies of 73.9% of mothers (147/199) were captured in the study; (60.4%) (150/248) and 31.1% (87/280) children were exposed to HCQ and AZA, respectively. There were no significant differences in the frequency of congenital malformations or intrauterine growth restriction between children exposed or not to HCQ or AZA. AZA use was increased in women with a history of hypertension or renal disease. Although AZA was associated with low birth weight in univariate models, there was no significant association in multivariable models. In adjusted models, exposure to AZA was associated with increased reports of childhood infection requiring hospital management [odds ratio 2.283 (1.003, 5.198), P = 0.049]. CONCLUSIONS: There were no significant negative outcomes in children exposed to HCQ in pregnancy. AZA use was associated with increased reporting of childhood infection, which warrants further study.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Reynolds JA, Gayed M, Khamashta MA, et al. Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine. Rheumatology (Oxford). 2023. PMID: 35766806. doi:10.1093/rheumatology/keac372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。